Home/Filings/4/0001323885-22-000093
4//SEC Filing

Dahlquist Karl S. 4

Accession 0001323885-22-000093

CIK 0001323885other

Filed

Jul 4, 8:00 PM ET

Accepted

Jul 5, 4:24 PM ET

Size

4.9 KB

Accession

0001323885-22-000093

Insider Transaction Report

Form 4
Period: 2022-06-30
Dahlquist Karl S.
Chief Legal Officer
Transactions
  • Award

    Common Stock

    2022-06-30$34.73/sh+350$12,15523,490 total
Footnotes (2)
  • [F1]Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2022.
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2022, which is the last trading day of the applicable offering period. The closing price on June 30, 2022 was $40.86.

Issuer

AtriCure, Inc.

CIK 0001323885

Entity typeother

Related Parties

1
  • filerCIK 0001861996

Filing Metadata

Form type
4
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:24 PM ET
Size
4.9 KB